Acroscell announces the release of its comprehensive ionic screening library, the delivery of quality data and on-time performance guarantee to satisfy the demands in academic research and commercial analysis.
Shirley, USA - August 14, 2019 /MarketersMedia/ —
New York, Aug 14th, 2019 - Acroscell, the division of Creative Bioarray, focusing on offering a diverse portfolio of standard and customized drug safety & pharmacology assays and panels for drug screening and profiling with the cutting-edge electrophysiological screening platform, today announces the release of its comprehensive ionic screening library, the delivery of quality data and on-time performance guarantee to satisfy the demands in academic research and commercial analysis. This new release offers researchers with primary screening and functional profiling assays to help discover potential compounds targeting ion channels.
Acroscell has developed a comprehensive validation screening and assays as well as a library of stable channel expression cell lines for high throughput screening, lead optimization studies and selectivity analysis. Most importantly, the experienced in-house team enables ionic screening library to accelerate projects with the most advanced gold standard manual patch clamp technology, a variety of automated platform analysis for specific needs as well as the reliable screening turnaround time. As for the specific screening library channels, which are including Sodium Channels, Calcium Channels and TRP Channels etc., but way more than these mentioned.
TRP channel, as an important pharmacological target for specific new treatment options for patients, has attracted increasing attention worldwide. Acroscell empowers TRP channels with a new fluorescent dye - fluo-4 AM dye to target drug screening analysis, the implementation of high throughput screening for several TRP channels has been developed, including TRPC and TRPV channels as well as other TRP channel target screenings. Acroscell summarizes current state-of-the-art TRP channel studies with a focus on TRP channel activation, their physiological and pathophysiological functions, and their role as pharmacological targets to support future treatment options, especially for cardiovascular system, brain, immune system, cancer progression and tissue remodeling.
In addition, sodium channels are present in the membranes of most excitable cells and are involved in many cardiac or neuronal diseases. Due to the number of different sodium channels and their various expression patterns, the sodium channels offered in Acroscell have broad applicability, including the following areas: central nervous system disorders, pain research, cardiovascular disease and cancer therapy, etc. In drug screening, the sodium channels more closely mimic the diseased pathway, but with a greater sustained current, making the treatment easier to detect. Meanwhile, the long-term opening of sodium channels helps the drug to bind at lower concentrations to conduct thorough kinetic studies.
“All of our ionic screening tests are validated by experienced electrophysiologists under rigorously optimized SOP to ensure the highest quality and consistent data.” said Hannah Cole, the marketing director of Acroscell, “Our professionals also guarantee to provide customized projects for ion screening panel service.”
About Acroscell
As a mature division of Creative Bioarray, Acroscell definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, we are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerate drug development and improve research quality for worldwide projects.
Contact Info:
Name: Hannah Cole
Email: Send Email
Organization: Creative Bioarray
Address: 45-1 Ramsey Road, Shirley, Ny 11967, Usa
Phone: 6316197922
Website: https://www.creative-bioarray.com/
Source: MarketersMedia
Release ID: 88907906
